Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Gastroenterology

Understanding Your Tests and Risk Level

At a Glance

Ultrasound and liver blood tests help estimate whether a gallstone has moved into the common bile duct. Low-risk results may need no further duct testing, while intermediate or high risk may lead to MRCP, EUS, or ERCP.

If your doctor suspects gallstones or related complications, they will use a combination of imaging and blood tests to create a clear picture of what is happening inside your body. The goal of this process—called risk stratification—is to determine if stones have moved out of the gallbladder and into the common bile duct.

  • Gallbladder stones are inside the organ itself.
  • Common bile duct stones have escaped the gallbladder and are in the “main pipe” that drains bile into the intestine. The tests and treatments for these two situations differ.

The First Step: Transabdominal Ultrasound

An ultrasound is the preferred first-line test for diagnosing gallstones. It is non-invasive, uses sound waves instead of radiation, and is highly accurate for finding stones still inside the gallbladder [1].

  • Sensitivity: For stones in the gallbladder, ultrasound is quite sensitive (roughly 93%), though performance varies with the operator, body habitus, and stone size [2].
  • Common Bile Duct (CBD): Ultrasound is much less reliable for seeing stones that have moved into the bile duct, with a sensitivity often estimated around 73% for these “hidden” stones [3].
  • Dilation: Even if the ultrasound doesn’t see a stone in the duct directly, it can show if the duct is wider than normal (dilated). A dilated CBD is a clue that a stone might be causing a backup, but it is not absolute proof of an obstruction. Furthermore, a “normal” duct size varies with age and whether you have had your gallbladder removed previously [4].

Using Blood Tests to Measure Risk

Doctors use your blood work, specifically Liver Function Tests (LFTs), to see how well bile is flowing. However, blood tests alone are not diagnostic; they must be viewed in clinical context.

  • Bilirubin: If your total bilirubin is high (especially above 4 mg/dL), it is a strong signal of a possible blockage [5]. However, bilirubin can be transiently elevated or have non-biliary causes.
  • Alkaline Phosphatase (ALP): An elevation in this enzyme often suggests an obstruction in the bile ducts [4], but it too can rise for other reasons.
  • White Blood Cell Count (CBC) and Lipase: A high white cell count can indicate inflammation or infection (like cholecystitis), but a normal white cell count does not entirely exclude it. An elevated lipase level suggests the pancreas is inflamed (pancreatitis), but it usually needs to be at least three times the upper limit of normal, alongside compatible pain or imaging, to confirm the diagnosis [6][7].

Determining Your Risk Level

Based on your ultrasound and blood tests, your medical team will place you into one of three general risk categories for having stones in your bile duct (choledocholithiasis). These categories are clinician-applied and vary by guideline:

Risk Level Typical Findings Next Step
High Stone seen on ultrasound, high bilirubin (>4 mg/dL) plus a dilated duct, or signs of a duct infection (cholangitis). Usually proceed to ERCP to remove the stone [5].
Intermediate Abnormal liver tests or a dilated duct on ultrasound, but no stone clearly seen. Advanced imaging (MRCP or EUS) to evaluate the duct before doing anything invasive [8].
Low Normal liver tests and no duct dilation on ultrasound. No further duct testing is usually needed; proceed to standard gallbladder monitoring or routine surgery [9].

Note: Being low risk for a duct stone does not itself mean you need gallbladder surgery.

Advanced Imaging for Intermediate Risk

If you are at intermediate risk, your doctor will likely order a second, more detailed test to look for duct stones. This helps avoid unnecessary invasive procedures.

  • MRCP (Magnetic Resonance Cholangiopancreatography): This is a specialized MRI of your bile ducts. It is non-invasive and requires no sedation [8][10]. However, it may be unsuitable for patients with severe claustrophobia or certain medical implants.
  • EUS (Endoscopic Ultrasound): A doctor passes a thin tube with a tiny ultrasound probe down your throat while you are sedated. It is excellent for finding very small stones or “sludge,” but because it involves sedation, it carries minor procedural risks [8][11].

If an MRCP or EUS is negative, it significantly reduces the probability of a duct stone, though it does not guarantee the ducts are 100% clear (they can sometimes miss tiny stones or sludge). Your doctor will still monitor your symptoms, bilirubin levels, and clinical condition.

ERCP: An Invasive Treatment

If a stone in the bile duct is confirmed or highly suspected, a procedure called ERCP (Endoscopic Retrograde Cholangiopancreatography) is usually performed. ERCP uses a scope passed through your mouth and into the small intestine to physically remove the stone from the duct.

ERCP is highly effective, but it is invasive and carries important risks, such as post-ERCP pancreatitis, bleeding, infection, and bowel perforation [9][12]. For this reason, it is generally used for treatment and urgent drainage, rather than as a routine diagnostic test just to “look around.”

Common questions in this guide

What is the first test for suspected gallstones?
A transabdominal ultrasound is usually the first test because it is noninvasive and good at finding stones in the gallbladder. It is less reliable for stones in the common bile duct, so blood tests and other imaging may be needed.
Does a widened common bile duct mean I have a bile duct stone?
Not necessarily. A widened common bile duct is a clue that bile flow may be blocked, but it is not proof of a stone; normal duct size also varies with age and whether the gallbladder has been removed. Clinicians interpret it with symptoms, liver tests, and imaging.
What does intermediate risk of a common bile duct stone mean?
Intermediate risk means the ultrasound or liver tests are abnormal, but no duct stone is clearly visible. Doctors often use MRCP, a specialized MRI, or EUS, an ultrasound performed from inside the digestive tract, to look more closely before an invasive procedure.
When is ERCP used for gallstones?
ERCP is generally used to treat a confirmed or highly suspected common bile duct stone by removing it or draining the duct. It is not usually used just to look for a stone because it can cause pancreatitis, bleeding, infection, or bowel perforation.
What do bilirubin and other blood tests show with gallstones?
High bilirubin or alkaline phosphatase can suggest that a stone is blocking bile flow, but these results can have other causes and are not diagnostic by themselves. A high lipase level may support pancreatitis when it occurs with typical pain or imaging findings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the specific diameter of my common bile duct on the ultrasound, and how does that affect my risk level?
  2. 2.Are my liver function tests (LFTs) currently showing signs of a blockage, and which specific markers are elevated?
  3. 3.Based on my results, do you categorize me as 'low,' 'intermediate,' or 'high' risk for having a stone in my bile duct?
  4. 4.If I am at intermediate risk, would you recommend an MRCP or an EUS to further evaluate the duct before considering surgery?
  5. 5.If a stone is found in my bile duct, will it be removed during my gallbladder surgery or as a separate procedure like an ERCP?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    The Treatment of Gallstone Disease.

    Gutt C, Schläfer S, Lammert F

    Deutsches Arzteblatt international 2020; (117(9)):148-158.

    PMID: 32234195
  2. 2

    Bedside ultrasonography for acute gallstone disease: a diagnostic accuracy study of surgical registrars and emergency medicine physicians.

    MacDonald AA, Richardson M, Sue L, et al.

    ANZ journal of surgery 2020; (90(12)):2467-2471 doi:10.1111/ans.16169.

    PMID: 33216429
  3. 3

    Ultrasound versus liver function tests for diagnosis of common bile duct stones.

    Gurusamy KS, Giljaca V, Takwoingi Y, et al.

    The Cochrane database of systematic reviews 2015; CD011548 doi:10.1002/14651858.CD011548.

    PMID: 25719223
  4. 4

    Choledocholithiasis in acute calculous cholecystitis: guidelines and beyond.

    Reddy S, Jagtap N, Kalapala R, et al.

    Annals of gastroenterology 2021; (34(2)):247-252 doi:10.20524/aog.2020.0562.

    PMID: 33654367
  5. 5

    Low Detection Rates of Bile Duct Stones During Endoscopic Treatment for Highly Suspected Bile Duct Stones with No Imaging Evidence of Stones.

    Saito H, Iwasaki H, Itoshima H, et al.

    Digestive diseases and sciences 2023; (68(5)):2061-2068 doi:10.1007/s10620-022-07773-5.

    PMID: 36450977
  6. 6

    American College of Gastroenterology Guidelines: Management of Acute Pancreatitis.

    Tenner S, Vege SS, Sheth SG, et al.

    The American journal of gastroenterology 2024; (119(3)):419-437 doi:10.14309/ajg.0000000000002645.

    PMID: 38857482
  7. 7

    Clinical Presentation, Imaging, and Management of Acute Cholecystitis.

    Katabathina VS, Zafar AM, Suri R

    Techniques in vascular and interventional radiology 2015; (18(4)):256-65.

    PMID: 26615166
  8. 8

    Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones.

    Giljaca V, Gurusamy KS, Takwoingi Y, et al.

    The Cochrane database of systematic reviews 2015; CD011549 doi:10.1002/14651858.CD011549.

    PMID: 25719224
  9. 9

    Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline.

    Manes G, Paspatis G, Aabakken L, et al.

    Endoscopy 2019; (51(5)):472-491 doi:10.1055/a-0862-0346.

    PMID: 30943551
  10. 10

    Predictors for choledocholitiasis in patients undergoing endoscopic ultrasound.

    Vaynshtein J, Sabbag G, Pinsk I, et al.

    Scandinavian journal of gastroenterology 2018; (53(3)):335-339 doi:10.1080/00365521.2018.1435716.

    PMID: 29421933
  11. 11

    EUS assessment for intermediate risk of choledocholithiasis after a negative magnetic resonance cholangiopancreatography.

    Wee D, Izard S, Grimaldi G, et al.

    Endoscopic ultrasound 2020; (9(5)):337-344 doi:10.4103/eus.eus_57_20.

    PMID: 33106466
  12. 12

    The use of endoscopic ultrasound in tandem with endoscopic retrograde cholangiopancreatography in the 2019 American Society for Gastrointestinal Endoscopy guideline for patients at high risk of choledocholithiasis can help to avoid diagnostic endoscopic retrograde cholangiopancreatography in individuals without ascending cholangitis.

    Sirinawasatien A, Chanchairungcharoen J, Yaowmaneerat T, et al.

    DEN open 2025; (5(1)):e70058 doi:10.1002/deo2.70058.

    PMID: 39845698

This page explains how gallstone tests estimate common bile duct stone risk for informational purposes only and does not constitute medical advice. Ask your clinician to interpret your results and recommend the safest next step.

Get notified when new evidence is published on cholecystolithiasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.